Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Resistance to antibiotics is one of the key challenges to healthcare this century. Tackling it will require sweeping changes to antibiotic use in animals⁠—and researchers from Oxford University Clinical Research Unit are rising to the challenge in Vietnam, with a rigorous test of programmes among farmers.

Antibiotic resistance (AMR) is one of this century’s biggest healthcare challenges. In Vietnam, the AMR rate is among the highest in Asia. One reason for this high rate of AMR is excessive and inappropriate usage of antimicrobials in poultry production. When AMR resistant bacteria show up in poultry, they can also be transmitted to humans, leading to infections in people that are very hard to treat.

Recognizing this problem, researchers at OUCRU have worked with farmers in a project called ViParc– which stands for Vietnamese Platform for Antimicrobial Reduction in Chicken production. Started in 2016, this project aims to reduce the reliance on antibiotics in livestock production. We hope that the project will raise the awareness of farmers and share an important message ‘healthy chickens do not need antibiotics’. Healthy livestock, healthy community!

Similar stories

Supporting children to grow smarter, not just taller

EOCRU OUCRU

Anuraj Shankar from our EOCRU unit in Jakarta, Indonesia, with Elizabeth Prado and Leila Larson describe a meta-analysis showing that responsive caregiving boosts infants’ brain development. Parenting group sessions and home visits improve cognitive, language, and motor skills. And nutrition-only programmes have much less effect than comprehensive interventions.

World’s largest clinical trial for COVID-19 treatments expands internationally

EOCRU OCGHR OUCRU OUCRU-Nepal Research

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.

Indonesia’s decision to prioritise COVID-19 vaccination to citizens aged 18-59 years old questionable

EOCRU MORU OUCRU

The Indonesian government policy to exclude the elderly in the first phase of the COVID-19 vaccination program could hinder the vaccine’s impact in lowering mortality rates. COVID-19 mortality rates in Indonesia, the highest in Southeast Asia, are dominated by those in the 60 years and above age bracket. In this article published in The Conversation, Kartika Saraswati and fellow DPhil students elaborate how, by prioritising vaccination for elderly, Indonesia may optimally reduce the hospital burden and COVID-19 deaths amidst a limited vaccine supply during the first vaccination phase.

Pearl Gan, OUCRU Photographer in Residence, selected for the Lancet Highlights 2020

OUCRU

Congratulations to Pearl Gan, OUCRU Photographer in Residence, for her winning image selected for the Lancet Highlights 2020: Framing Health Stories. Despite the difficulties of this pandemic year, The Lancet received fascinating and varied entries for our Highlights 2020 photography competition. 15 striking photographs were selected. Each picture captures a unique moment, highlighting a health story.

Youth against antimicrobial resistance

OUCRU Public Engagement

The YAAR! project, bringing together young people from four countries in the Global South to help combat the challenge of antimicrobial resistance (AMR), or drug resistant infections.

Oxford Global Research

General KWTRP MORU OCGHR OUCRU

Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. To showcase our global research, the University launched a Global Research Map, highlighting areas of research we are conducting overseas.